Patents by Inventor Satoshi Mashiko

Satoshi Mashiko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SENSOR, DEVICE, SYSTEM, AND MANUFACTURING METHOD FOR PRODUCT
    Publication number: 20230129177
    Abstract: A sensor includes a structure and a detector. The detector is arranged to detect a deformation of the structure. The structure has at least four elastic sections. The at least four elastic sections are discretely disposed in an imaginary plane.
    Type: Application
    Filed: October 25, 2022
    Publication date: April 27, 2023
    Inventors: Satoshi Mashiko, Haruhiko Horiguchi, Akira Yajima, Takayuki Ogawara, Shuuichi Sato, Kohei Oyu, Haruyasu Ishikawa, Shoji Sasaki, Yoshiyuki Beniya, Yu Takahashi, Yoshiharu Irei
  • Nucleic acid encoding monkey QRFP
    Patent number: 7696339
    Abstract: There are provided non-human primate and rat GPR103 genes and proteins and a compound evaluation method employing the genes or proteins. There are also provided highly useful novel ligands for functional analysis of the GPR103 genes and proteins and for the compound evaluation. The nucleic acids or proteins having the sequences listed as SEQ ID NOS: 1 to 4 provide non-human primate or rat GPR103 genes and proteins and information based on the genes and proteins. The genes and proteins can be used for evaluation of compounds. The nucleic acids or proteins having the sequence listed as SEQ ID NO: 5 or 6 provide a GPR103 ligand.
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: April 13, 2010
    Assignee: Banyu Pharmaceutical Co., Ltd.
    Inventors: Hideki Sano, Hisashi Iwaasa, Satoshi Mashiko
  • Novel monkey GPR103 and monkey QRFP and method of evaluating compound by using GPR103
    Publication number: 20090176243
    Abstract: There are provided non-human primate and rat GPR103 genes and proteins and a compound evaluation method employing the genes or proteins. There are also provided highly useful novel ligands for functional analysis of the GPR103 genes and proteins and for the compound evaluation. The nucleic acids or proteins having the sequences listed as SEQ ID NOS: 1 to 4 provide non-human primate or rat GPR103 genes and proteins and information based on the genes and proteins. The genes and proteins can be used for evaluation of compounds. The nucleic acids or proteins having the sequence listed as SEQ ID NO: 5 or 6 provide a GPR103 ligand.
    Type: Application
    Filed: June 26, 2008
    Publication date: July 9, 2009
    Inventors: Hideki Sano, Hisashi Iwaasa, Satoshi Mashiko
  • Method for examining obesity or leanness
    Patent number: 7510833
    Abstract: In the examination of obesity or leanness, the examination is based on the expression level of the MCP-1 gene or the MCP-1 protein in a tissue or cell analyte, or on the polymorphism in the gene. In the evaluation of compounds, including screening for therapeutic agents for obesity or leanness, the properties of the MCP-1 gene or the MCP-1 protein are utilized to carry out the evaluation.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: March 31, 2009
    Assignee: Banyu Pharmaceutical Co., Ltd.
    Inventors: Hidehito Kotani, Hiraku Itadani, Hiromitsu Araki, Kazuhiko Takahashi, Satoshi Mashiko, Akane Ishihara, Akio Kanatani
  • Nucleic acid encoding monkey Gpr103
    Patent number: 7422898
    Abstract: There are provided non-human primate and rat GPR103 genes and proteins and a compound evaluation method employing the genes or proteins. There are also provided highly useful novel ligands for functional analysis of the GPR103 genes and proteins and for the compound evaluation. The nucleic acids or proteins having the sequences listed as SEQ ID NOS: 1 to 4 provide non-human primate or rat GPR103 genes and proteins and information based on the genes and proteins. The genes and proteins can be used for evaluation of compounds. The nucleic acids or proteins having the sequence listed as SEQ ID NO: 5 or 6 provide a GPR103 ligand.
    Type: Grant
    Filed: April 14, 2005
    Date of Patent: September 9, 2008
    Assignee: Banyu Pharmaceutical Co., Ltd.
    Inventors: Hideki Sano, Hisashi Iwaasa, Satoshi Mashiko
  • Novel Monkey Gpr103 and Monkey Qrfp and Method of Evaluating Compound By Using Gpr103
    Publication number: 20080009016
    Abstract: There are provided non-human primate and rat GPR103 genes and proteins and a compound evaluation method employing the genes or proteins. There are also provided highly useful novel ligands for functional analysis of the GPR103 genes and proteins and for the compound evaluation. The nucleic acids or proteins having the sequences listed as SEQ ID NOS: 1 to 4 provide non-human primate or rat GPR103 genes and proteins and information based on the genes and proteins. The genes and proteins can be used for evaluation of compounds. The nucleic acids or proteins having the sequence listed as SEQ ID NO: 5 or 6 provide a GPR103 ligand.
    Type: Application
    Filed: April 14, 2005
    Publication date: January 10, 2008
    Inventors: Hideki Sano, Hisashi Iwaasa, Satoshi Mashiko
  • Method For Examining Obesity Or Leanness
    Publication number: 20070031833
    Abstract: In the examination of obesity or leanness, the examination is based on the expression level of the MCP-1 gene or the MCP-1 protein in a tissue or cell analyte, or on the polymorphism in the gene. In the evaluation of compounds, including screening for therapeutic agents for obesity or leanness, the properties of the MCP-1 gene or the MCP-1 protein are utilized to carry out the evaluation.
    Type: Application
    Filed: March 12, 2004
    Publication date: February 8, 2007
    Applicant: BANYU PHARMACEUTICAL CO., LTD.
    Inventors: Hidehito Kotani, Hiraku Itadani, Hiromitsu Araki, Kazuhiko Takahashi, Satoshi Mashiko, Akane Ishihara, Akio Kanatani